Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20121
20142
20154
20161
20182
20202
20212
20232
20242
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed8
Unknown status7
Not yet recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University9
Changhai Hospital2
Akeso1
Albert Einstein College of Medicine1
Astellas Pharma Global Development, Inc.1
Biotech Pharmaceutical Co., Ltd.1
Evopoint Biosciences Inc.1
FutureGen Biopharmaceutical (Beijing) Co., Ltd1
Genfleet Therapeutics (Shanghai) Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms31
Adenocarcinoma1
Biliary Tract Neoplasms1
Carcinoma, Pancreatic Ductal1
Digestive System Diseases1
Digestive System Neoplasms1
Duodenal Neoplasms1
Endocrine Gland Neoplasms1
Endocrine System Diseases1
Nausea1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.